GDC0068s
GDC0068s, also known as RG0068, is a small molecule drug candidate that has been investigated for its potential therapeutic applications. It functions as an inhibitor of the Bruton's tyrosine kinase (BTK) enzyme. BTK is a critical signaling molecule in B-cell development and function, and its aberrant activity is implicated in various B-cell malignancies and autoimmune diseases.
The development of GDC0068s was primarily aimed at targeting these conditions by blocking the BTK signaling
Clinical trials were conducted to assess the safety and efficacy of GDC0068s in human patients. These trials
While GDC0068s showed promising results in some preclinical and early clinical studies, its development has faced